About this trial
The goal of this randomized prospective clinical trial is to examine whether phenotypic traits, psychological characteristics, assessed by STAI (engl. The State-Trait Anxiety Inventory) and IPIP50S (engl. International Personality Item Pool) questionnaires, and patients' self-efficacy, assessed by SEMSA (engl. Self-Eficacy Measure for Sleep Apnea) questionnaire, are associated with CPAP adherence after three months of use. The study also evaluates whether a motivational phone call one month after therapy initiation improves CPAP adherence at the three-month follow-up. The main questions it aims to answer are:
* Are phenotypic and psychological traits associated with adherence to CPAP therapy after 3 months of treatment? * Can a single motivational telephone intervention, one month after initiating CPAP therapy, significantly improve CPAP adherence at the three-month follow-up compared to no intervention? Researchers will compare patients who receive a phone call to those who do not, to see if this simple intervention leads to better CPAP adherence after three months of use.
Participants will:
* Undergo polysomnography before starting CPAP therapy, * Complete three questionnaires (IPIP50S, STAI, SEMSA) before starting CPAP therapy, * Be randomly assigned to either receive a motivational phone call one month after starting CPAP therapy or to a control group without any phone call, * Be invited for a follow-up after three months of CPAP use to download and analyze CPAP adherence data from their CPAP devices.
Eligibility criteria
Qualifiers
Participants aged 18 years or older
Diagnosis of severe obstructive sleep apnea (OSA), defined as AHI ≥30
Signed informed consent for participation in the study
Adequate physical and psychological capacity to participate in the intervention and complete questionnaires
Disqualifiers
Presence of central sleep apnea or other primary sleep disorders
Cognitive impairment or psychiatric conditions that may hinder the ability to follow instructions or complete questionnaires
Previous experience with CPAP therapy prior to study enrollment
Significant comorbidities (e.g. unstable cardiovascular disease, advanced pulmonary disease) that may interfere with study outcomes
Trial design
Treatments tested in this trial
- Motivational Telephone Call